All In Biotech

Drug Trial Radar · NCT02243319

Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904

A Randomized, Open Label, Crossover Study to Investigate the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904 in Healthy Male Subjects

Last checked: Nov 19, 2026Latest source record: Oct 20, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

24

Actual

Start

Sep 2014

Primary completion

Dec 2014

Study completion Dec 2014

Sponsor

Sponsor type
Industry
First posted
Sep 17, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
Who can join
Male only, from 19 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the pharmacokinetic drug interactions between HGP1201 and HGP0904

Conditions

  • Healthy

Interventions

  • HGP1201Drug

  • HGP0904Drug

  • HGP0904 and HGP1201 co-administraionDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cmax,ss of HGP1201, HGP0904Time frame: 1D 0h(predose), 8D 0h, 9D 0h, 0.5, 1, 1.5, 2, 3, 4, 6, 8, 10, 12, 10D 0h, 11D 0h, 12D 0h
  2. AUCτ,ss of HGP1201, HGP0904Time frame: 1D 0h(predose), 8D 0h, 9D 0h, 0.5, 1, 1.5, 2, 3, 4, 6, 8, 10, 12, 10D 0h, 11D 0h, 12D 0h

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Asan Medical Center

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.